Evidence map›Paper›PMID 27956747›Full record

ArticleMolecular psychiatry2018

Acute engagement of G

C M Mazzone, D Pati, M Michaelides, J DiBerto, J H Fox, G Tipton, C Anderson, K Duffy, J M McKlveen, J A Hardaway and 6 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. 5-HTBrain sciences · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Bed Nucleus of the Stria Terminalis (BNST) neurons containing the serotonin 5HTNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  17. Article
  18. Review
  19. Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

C M MazzoneNeurobiology Curriculum, University of North Carolina, Chapel Hill, NC, USA.
D PatiLaboratory of Molecular Neurophysiology, Bowles Center for Alcohol Studies, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
M MichaelidesFishberg Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
J DiBertoLaboratory of Molecular Neurophysiology, Bowles Center for Alcohol Studies, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
J H FoxDepartment of Psychology, University of Vermont, Burlington, VT, USA.
G TiptonLaboratory of Molecular Neurophysiology, Bowles Center for Alcohol Studies, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
C AndersonCenter for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, NC, USA.
K DuffyLaboratory of Molecular Neurophysiology, Bowles Center for Alcohol Studies, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
J M McKlveenLaboratory of Molecular Neurophysiology, Bowles Center for Alcohol Studies, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
J A HardawayLaboratory of Molecular Neurophysiology, Bowles Center for Alcohol Studies, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
S T MagnessDepartment of Medicine, University of North Carolina, Chapel Hill, NC, USA.
W A FallsDepartment of Psychology, University of Vermont, Burlington, VT, USA.
S E HammackDepartment of Psychology, University of Vermont, Burlington, VT, USA.
Z A McElligottDepartment of Psychiatry, University of North Carolina, Chapel Hill, NC, USA.
Y L HurdFishberg Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
T L KashLaboratory of Molecular Neurophysiology, Bowles Center for Alcohol Studies, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
University of North Carolina at Chapel Hill · USUniversity of Vermont · USAllen Institute for Brain Science · USIcahn School of Medicine at Mount Sinai · US

Funding

UNC ARC Information/Dissemination CoreP60AA011605 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Thomas L. Kash · 2003 to 2026
$46.3M
PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Temitope O. Keku · 1985 to 2026
$30.5M
Biobehavioral Imaging and Molecular Neuropsychopharmacology of Substance Abuse MechanismsZIADA000069 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI MICHAELIDES, MICHAEL · 2016 to 2025
$18.9M
Supplement to Molecular and Cellular Studies on Alcohol's ActionsT32AA007573 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FULTON T CREWS, Thomas L. Kash · 1997 to 2026
$9.3M
The Opioid mesolimbic system in heroin abuseR01DA015446 · NIDA · KAROLINSKA INSTITUTE · PI HURD, YASMIN L. · 2002 to 2018
$7.1M
Probing Ethanol Induced Acceleration of Hindbrain and Amygdalar Pathology in an Alzheimer’s Disease ModelU01AA020911 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Thomas L. Kash, Zoe Anastasia McElligott · 2012 to 2026
$5.8M
The Role of Serotonin in Alcohol-Withdrawal Induced AnxietyR01AA019454 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Thomas L. Kash · 2010 to 2026
$5.6M
Neurodevelopmental Effects of Cannabis and its Epigenetic RegulationR01DA030359 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HURD, YASMIN L. · 2011 to 2020
$5.5M
MOLECULAR AND CELLULAR PATHOGENESIS IN ALCOHOLISMP50AA011605 · NIAAA · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI CREWS, FULTON T · 1998 to 2002
$4.9M
TRAINING IN PHARMACOLOGY OF DRUGS OF ABUSET32DA007135 · NIDA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI DEVI, LAKSHMI A · 1985 to 2018
$4.9M
PACAP and the Response to Stressors: Neural MechanismsR01MH097988 · NIMH · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HAMMACK, SAYAMWONG E., MAY, VICTOR · 2012 to 2023
$3.7M
DREADD2.0: AN ENHANCED CHEMOGENETIC TOOLKITU01MH105892 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JIN, JIAN, KASH, THOMAS L. · 2014 to 2016
$3.0M
NIAAA NIH HHS F31 AA023440NIAAA NIH HHS K01 AA023555NIAAA NIH HHS P50 AA011605NIAAA NIH HHS P60 AA011605NIAAA NIH HHS R01 AA019454NIAAA NIH HHS T32 AA007573NIAAA NIH HHS U01 AA020911NIDA NIH HHS R01 DA015446NIDA NIH HHS R01 DA030359NIDA NIH HHS R01 DA033660NIDA NIH HHS R56 DA015446NIDA NIH HHS T32 DA007135NIDDK NIH HHS P30 DK034987NIMH NIH HHS R01 MH097988NIMH NIH HHS R21 MH080935NIMH NIH HHS T32 MH076694NIMH NIH HHS U01 MH105892
6 · The paper itself

Abstract

The bed nucleus of the stria terminalis (BNST) is a brain region important for regulating anxiety-related behavior in both humans and rodents. Here we used a chemogenetic strategy to investigate how engagement of G protein-coupled receptor (GPCR) signaling cascades in genetically defined GABAergic BNST neurons modulates anxiety-related behavior and downstream circuit function. We saw that stimulation of vesicular γ-aminobutyric acid (GABA) transporter (VGAT)-expressing BNST neurons using hM3Dq, but neither hM4Di nor rM3Ds designer receptors exclusively activated by a designer drug (DREADD), promotes anxiety-like behavior. Further, we identified that activation of hM3Dq receptors in BNST VGAT neurons can induce a long-term depression-like state of glutamatergic synaptic transmission, indicating DREADD-induced changes in synaptic plasticity. Further, we used DREADD-assisted metabolic mapping to profile brain-wide network activity following activation of G

Indexed as

AnimalsAnti-Anxiety AgentsAnxietyBrain MappingCannabinoid Receptor AntagonistsClozapineDark AdaptationDisease Models, AnimalEstrenesExcitatory Postsynaptic PotentialsExploratory BehaviorGreen Fluorescent ProteinsGTP-Binding Protein alpha Subunits, Gq-G11In Vitro TechniquesMaleMaze Learning1-(3-chlorophenyl)piperazine1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dioneAnti-Anxiety AgentsCannabinoid Receptor AntagonistsClozapineclozapine N-oxideEstrenesGreen Fluorescent ProteinsGTP-Binding Protein alpha Subunits, Gq-G11Phosphodiesterase InhibitorsPiperazinesPyrrolidinonesReceptors, DrugRimonabantRNA, MessengerSerotonin Receptor AgonistsSodium Channel BlockersTetrodotoxinVesicular Inhibitory Amino Acid Transport ProteinsViaat protein, mouse

Identifiers

PMID27956747
PMCPMC5468515
OpenAlexW2563926210

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.